OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer

International Journal of Oncology

Volumn 27, Issue 5, 2005, Pages 1315-1320

  Arcand, Suzanna L ^a   Provencher, Diane ^b,c   Mes Masson, Anne Marie ^b,c   Tonin, Patricia N ^a,d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Chromosome 3p25; Loss of heterozygosity; OGG1; Ovarian cancer; TP53

Indexed keywords

DNA GLYCOSYLTRANSFERASE; OXOGUANINE GLYCOSYLASE 1, HUMAN; PROTEIN P53;

ALLELIC IMBALANCE; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 3; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; OVARY TUMOR; RISK FACTOR;

ALLELIC IMBALANCE; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 3; DNA GLYCOSYLASES; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644659346     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.5.1315     Document Type: Article

References (33)

1. Goode EL, Ulrich CM and Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530,2002.
2. Boiteux S and Radicella JP: The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377: 1-8,2000.
3. Shibutani S, Takeshita M and Grollman AP: Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431-434, 1991.
4. Moriya M and Grollman AP: Mutations in the mutY gene of Escherichia coli enhance the frequency of targeted G:C → T:A transversions induced by a single 8-oxoguanine residue in single-stranded DNA. Mol Gen Genet 239: 72-76,1993.
5. Dherin C, Radicella JP. Dizdaroglu M and Boiteux S: Excision of oxidativcly damaged DNA bases by the human alpha-hOgg1 protein and the polymorphic alpha-hOgg1(Ser326Cys) protein which is frequentlv found in human populations. Nucleic Acids Res 27: 4001-4007, 1999.
6. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, Nohmi T, Kasai H and Yokota J: Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16: 3219-3225, 1998.
7. Lounis H, Mes-Masson AM, Dion F, Bradley WE, Seymour RJ, Provencher D and Tonin PN: Mapping of chromosome 3p deletions in human epithelial ovarian tumors. Oncogene 17: 2359-2365,1998.
8. Fullwood P, Marchini S, Rader JS. Martinez A, Macartney D, Broggini M, Morelli C, Barbanti-Brodano G, Maher ER and Latif F: Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res 59: 4662-4667, 1999.
9. Manderson EN, Presneau N, Provencher D, Mes-Masson AM and Tonin PN: Comparative analysis of loss of heterozygosity of specific chromosome 3,13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Mol Carcinog 34: 78-90,2002.
10. Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, et al: Localization of a novel susceptibility aene for familial ovarian cancer to chromosome 3p22-p25. Hum Mol Genet 10: 1421-1429,2001.
11. Pieretti M, Khattar NH and Smith SA: Common polymorphisms and somatic mutations in human base excision repair genes in ovarian and endometrial cancers. Mutat Res 432: 53-59, 2001.
12. Manderson EN, Mes-Masson AM, Novak J, Lee PD, Provencher D, Hudson TJ and Tonin PN: Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays. Genome Res 12: 112-121, 2002.
13. Aunoble B, Sanches R, Didier E and Bignon YJ: Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 16: 567-576, 2000.
14. Lounis H, Provencher D, Godbout C, Fink D, Milot MJ and Mes-Masson AM: Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies. Exp Cell Res 215: 303-309, 1994.
15. Scriver CR: Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2: 69-101,2001.
16. Le Marchand L, Donlon T, Lum-Jones A, Seifried A and Wilkens LR: Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 11: 409-412, 2002.
17. Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P and Narod SA: Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 63: 1341-1351,1998.
18. Manning AP, Abelovich D, Ghadirian P, Lambert JA, Frappier D, Provencher D, Robidoux A, Peretz T, Narod SA, Mes-Masson AM, et al: Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered 52: 116-120,2001.
19. Oros KK, Ghadirian P, Greenwood CM, Perret C, Shen Z, Paredes Y, Arcand SL, Mes-Masson AM, Narod SA, Foulkes WD, et al: Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int J Cancer 112: 411-419,2004.
20. Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA, et al: Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 62: 2253-2257, 2002.
21. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, Morris BJ, Baba S, Ohno Y, Gao C, et al: hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 8: 669-674,1999.
22. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhalder B, Dienemann H, Kayser K, Schulz V, Drings P and Bartsch H: hOGGl polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a Caucasian population. Int J Cancer 88: 932-937, 2000.
23. Blons H, Radicella JP, Laccourreye O, Bråsnu D, Beaune P, Boiteux S and Laurent-Puig P: Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer. Mol Carcinog 26: 254-260,1999.
24. Slupska MM, Luther WM, Chiang JH, Yang H and Miller JH: Functional expression of hMYH, a human homolog of the Escherichia coli MutY protein. J Bacteriol 181: 6210-6213, 1999.
25. Yang H, Clendenin WM, Wong D, Demple B, Slupska MM, Chiang JH and Miller JH: Enhanced activity of adenine-DNA glycosylase (Myh) by apurinic/apyrimidinic endonuclease (Apel) in mammalian base excision repair of an A/GO mismatch Nucleic Acids Res 29: 743-752, 2001.
26. Bruner SD, Norman DP and Verdine GL: Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 403: 859-866, 2000.
27. Hardie LJ, Briggs JA, Davidson LA, Allan JM, King RF, Williams GI and Wild CP: The effect of hOGGl and glutathione peroxidase I genotypes and 3p chromosomal loss on 8-hydroxydeoxyguanosine levels in lung cancer. Carcinogenesis 21: 167-172,2000.
28. Osterod M, Hollenbach S, Hengstler JG, Barnes DE, Lindahl T and Epe B: Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Oggl) deficient mice. Carcinogenesis 22: 1459-1463, 2001.
29. Minowa O, Arai T, Hirano M, Monden Y, Nakai S, Fukuda M, Itoh M, Takano H, Hippou Y, Aburatani H, et al: Mmh/Oggl gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci USA 97: 4156-4161,2000.
30. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T and Barnes DE: Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 96: 13300-13305, 1999.
31. Arai T, Kelly VP, Minowa O, Noda T and Nishimura S: High accumulation of oxidative DNA damage, 8-hydroxyguanine, in Mmh/Oggl deficient mice by chronic oxidative stress. Carcinogenesis 23: 2005-2010, 2002.
32. Xie Y, Yang H, Cunanan C, Okamoto K, Shibata D, Pan J, Barnes DE, Lindahl T, Mcllhatton M, Fishel R, et al: Deficiencies in mouse Myh and Oggl result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res 64: 3096-3102, 2004.
33. Hazra TK, Izumi T, Kow YW and Mitra S: The discovery of a new family of mammalian enzymes for repair of oxidatively damaged DNA, and its physiological implications. Carcinogenesis 24: 155-157,2003.